Les infections respiratoires sont-elles fréquentes ?
Oui, les enfants avec cette condition sont plus susceptibles de développer des infections respiratoires.
Infections respiratoiresEnfantsComplications
#4
Quels sont les risques à long terme ?
Les risques à long terme incluent des problèmes cardiaques chroniques et des limitations d'activité.
Risques à long termeProblèmes cardiaquesLimitations d'activité
#5
Comment prévenir les complications ?
Un suivi médical régulier et un traitement approprié peuvent aider à prévenir les complications.
PréventionSuivi médicalComplications
Facteurs de risque
5
#1
Quels sont les facteurs de risque génétiques ?
Des antécédents familiaux de malformations cardiaques augmentent le risque de cette condition.
Facteurs de risqueGénétiqueMalformations cardiaques
#2
L'âge maternel influence-t-il le risque ?
Oui, les femmes de plus de 35 ans ont un risque accru de donner naissance à un enfant atteint.
Âge maternelFacteurs de risqueGrossesse
#3
Les maladies maternelles affectent-elles le risque ?
Oui, des maladies comme le diabète ou le lupus peuvent augmenter le risque de malformations cardiaques.
Maladies maternellesDiabèteLupus
#4
L'exposition à des toxines est-elle un facteur ?
Oui, l'exposition à des toxines environnementales pendant la grossesse peut augmenter le risque.
ToxinesEnvironnementFacteurs de risque
#5
Le tabagisme maternel influence-t-il le risque ?
Oui, le tabagisme pendant la grossesse est associé à un risque accru de malformations cardiaques.
TabagismeGrossesseFacteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Persistance du canal artériel : Questions médicales les plus fréquentes",
"headline": "Persistance du canal artériel : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Persistance du canal artériel : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-06",
"dateModified": "2026-08-25",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Persistance du canal artériel"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Cardiopathies congénitales",
"url": "https://questionsmedicales.fr/mesh/D006330",
"about": {
"@type": "MedicalCondition",
"name": "Cardiopathies congénitales",
"code": {
"@type": "MedicalCode",
"code": "D006330",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C16.131.240.400"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Persistance du canal artériel",
"alternateName": "Ductus Arteriosus, Patent",
"code": {
"@type": "MedicalCode",
"code": "D004374",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Shyam Sathanandam",
"url": "https://questionsmedicales.fr/author/Shyam%20Sathanandam",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, Division of Pediatric Cardiology, University of Tennessee Health Science Center, Le Bonheur Children's Hospital, 51 N Dunlap street, Memphis, TN 38105, USA. Electronic address: shyam@uthsc.edu."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Souvik Mitra",
"url": "https://questionsmedicales.fr/author/Souvik%20Mitra",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, Dalhousie University, G-2214, 5850/5980 University Avenue, Halifax, Nova Scotia B3K 6R8, Canada; Department of Community Health & Epidemiology, Dalhousie University, G-2214, 5850/5980 University Avenue, Halifax, Nova Scotia B3K 6R8, Canada. Electronic address: https://twitter.com/souvik_neo."
}
},
{
"@type": "Person",
"name": "Ranjit Philip",
"url": "https://questionsmedicales.fr/author/Ranjit%20Philip",
"affiliation": {
"@type": "Organization",
"name": "Division of Pediatric Cardiology, University of Tennessee Health Science Center, Le Bonheur Children's Hospital, Memphis, Tennessee."
}
},
{
"@type": "Person",
"name": "Jeff Reese",
"url": "https://questionsmedicales.fr/author/Jeff%20Reese",
"affiliation": {
"@type": "Organization",
"name": "Division of Neonatology, Vanderbilt University Medical Center, Nashville, Tennessee; and."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Stenting of the Patent Ductus Arteriosus.",
"datePublished": "2024-03-22",
"url": "https://questionsmedicales.fr/article/38839174",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.iccl.2024.02.002"
}
},
{
"@type": "ScholarlyArticle",
"name": "Patent Ductus Arteriosus Occlusion in Premature Infants.",
"datePublished": "2024-03-19",
"url": "https://questionsmedicales.fr/article/38839169",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.iccl.2024.02.001"
}
},
{
"@type": "ScholarlyArticle",
"name": "Efficacy of paracetamol in the management of hemodynamically significant patent ductus arteriosus in preterm newborns.",
"datePublished": "2024-07-05",
"url": "https://questionsmedicales.fr/article/39078178",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4103/ijp.ijp_45_21"
}
},
{
"@type": "ScholarlyArticle",
"name": "Retrograde cerebral embolism and pulmonary embolism caused by patent ductus arteriosus: a case report.",
"datePublished": "2024-06-27",
"url": "https://questionsmedicales.fr/article/38937830",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13019-024-02901-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.",
"datePublished": "2023-11-01",
"url": "https://questionsmedicales.fr/article/38015504",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1001/jamanetworkopen.2023.45299"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Malformations et maladies congénitales, héréditaires et néonatales",
"item": "https://questionsmedicales.fr/mesh/D009358"
},
{
"@type": "ListItem",
"position": 3,
"name": "Malformations",
"item": "https://questionsmedicales.fr/mesh/D000013"
},
{
"@type": "ListItem",
"position": 4,
"name": "Malformations cardiovasculaires",
"item": "https://questionsmedicales.fr/mesh/D018376"
},
{
"@type": "ListItem",
"position": 5,
"name": "Cardiopathies congénitales",
"item": "https://questionsmedicales.fr/mesh/D006330"
},
{
"@type": "ListItem",
"position": 6,
"name": "Persistance du canal artériel",
"item": "https://questionsmedicales.fr/mesh/D004374"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Persistance du canal artériel - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Persistance du canal artériel",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-09-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Persistance du canal artériel",
"description": "Comment diagnostique-t-on la persistance du canal artériel ?\nQuels examens complémentaires sont utilisés ?\nQuels signes cliniques indiquent un canal artériel persistant ?\nÀ quel âge peut-on détecter cette malformation ?\nQuels sont les critères de gravité lors du diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D004374#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Persistance du canal artériel",
"description": "Quels sont les symptômes courants chez les nourrissons ?\nComment se manifeste la persistance du canal artériel chez les enfants ?\nY a-t-il des signes d'insuffisance cardiaque ?\nQuels symptômes peuvent indiquer une complication ?\nLes symptômes varient-ils selon l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D004374#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Persistance du canal artériel",
"description": "Peut-on prévenir la persistance du canal artériel ?\nQuels facteurs maternels influencent le risque ?\nLes vaccinations peuvent-elles aider ?\nQuel rôle joue la génétique dans cette condition ?\nLes soins prénatals sont-ils importants ?",
"url": "https://questionsmedicales.fr/mesh/D004374#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Persistance du canal artériel",
"description": "Quel est le traitement principal de cette condition ?\nDes médicaments sont-ils utilisés ?\nQuand la chirurgie est-elle recommandée ?\nQuelles sont les options de traitement non chirurgicales ?\nQuels soins post-opératoires sont nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D004374#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Persistance du canal artériel",
"description": "Quelles sont les complications possibles de cette condition ?\nComment l'hypertension pulmonaire se développe-t-elle ?\nLes infections respiratoires sont-elles fréquentes ?\nQuels sont les risques à long terme ?\nComment prévenir les complications ?",
"url": "https://questionsmedicales.fr/mesh/D004374#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Persistance du canal artériel",
"description": "Quels sont les facteurs de risque génétiques ?\nL'âge maternel influence-t-il le risque ?\nLes maladies maternelles affectent-elles le risque ?\nL'exposition à des toxines est-elle un facteur ?\nLe tabagisme maternel influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D004374#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on la persistance du canal artériel ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par échocardiographie et auscultation cardiaque."
}
},
{
"@type": "Question",
"name": "Quels examens complémentaires sont utilisés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des radiographies thoraciques et des IRM peuvent être réalisées pour évaluer la condition."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent un canal artériel persistant ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un souffle cardiaque, une tachypnée et une cyanose peuvent indiquer cette condition."
}
},
{
"@type": "Question",
"name": "À quel âge peut-on détecter cette malformation ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut être détectée dès la naissance ou lors des premiers mois de vie."
}
},
{
"@type": "Question",
"name": "Quels sont les critères de gravité lors du diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gravité dépend du diamètre du canal et des symptômes cliniques associés."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants chez les nourrissons ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les nourrissons peuvent présenter une respiration rapide, une fatigue et un retard de croissance."
}
},
{
"@type": "Question",
"name": "Comment se manifeste la persistance du canal artériel chez les enfants ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enfants peuvent avoir des infections respiratoires fréquentes et une fatigue à l'effort."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes d'insuffisance cardiaque ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des signes comme l'œdème, la dyspnée et la tachycardie peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une complication ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs thoraciques, une cyanose accrue ou un collapsus circulatoire peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent être plus subtils chez les enfants plus âgés et les adultes."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la persistance du canal artériel ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode garantie pour prévenir cette malformation congénitale."
}
},
{
"@type": "Question",
"name": "Quels facteurs maternels influencent le risque ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme le diabète, l'alcoolisme ou certaines infections pendant la grossesse peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles aider ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccinations ne préviennent pas directement la persistance du canal artériel."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la génétique dans cette condition ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antécédents familiaux de malformations cardiaques peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les soins prénatals sont-ils importants ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des soins prénatals appropriés peuvent aider à identifier des risques potentiels."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal de cette condition ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est la fermeture chirurgicale du canal artériel persistant."
}
},
{
"@type": "Question",
"name": "Des médicaments sont-ils utilisés ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des médicaments comme l'indométacine peuvent être administrés pour favoriser la fermeture."
}
},
{
"@type": "Question",
"name": "Quand la chirurgie est-elle recommandée ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est recommandée si le canal persiste après 6 mois ou en cas de symptômes."
}
},
{
"@type": "Question",
"name": "Quelles sont les options de traitement non chirurgicales ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements par cathéter peuvent être envisagés pour fermer le canal sans chirurgie ouverte."
}
},
{
"@type": "Question",
"name": "Quels soins post-opératoires sont nécessaires ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les soins incluent la surveillance des signes vitaux et la gestion de la douleur."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de cette condition ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'insuffisance cardiaque, l'hypertension pulmonaire et les infections."
}
},
{
"@type": "Question",
"name": "Comment l'hypertension pulmonaire se développe-t-elle ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle se développe en raison d'un flux sanguin excessif vers les poumons, causé par le canal ouvert."
}
},
{
"@type": "Question",
"name": "Les infections respiratoires sont-elles fréquentes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants avec cette condition sont plus susceptibles de développer des infections respiratoires."
}
},
{
"@type": "Question",
"name": "Quels sont les risques à long terme ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques à long terme incluent des problèmes cardiaques chroniques et des limitations d'activité."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et un traitement approprié peuvent aider à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque génétiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antécédents familiaux de malformations cardiaques augmentent le risque de cette condition."
}
},
{
"@type": "Question",
"name": "L'âge maternel influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes de plus de 35 ans ont un risque accru de donner naissance à un enfant atteint."
}
},
{
"@type": "Question",
"name": "Les maladies maternelles affectent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le diabète ou le lupus peuvent augmenter le risque de malformations cardiaques."
}
},
{
"@type": "Question",
"name": "L'exposition à des toxines est-elle un facteur ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines environnementales pendant la grossesse peut augmenter le risque."
}
},
{
"@type": "Question",
"name": "Le tabagisme maternel influence-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme pendant la grossesse est associé à un risque accru de malformations cardiaques."
}
}
]
}
]
}
Department of Pediatrics, Division of Pediatric Cardiology, University of Tennessee Health Science Center, Le Bonheur Children's Hospital, 51 N Dunlap street, Memphis, TN 38105, USA. Electronic address: shyam@uthsc.edu.
Publications dans "Persistance du canal artériel" :
Department of Pediatrics, Dalhousie University, G-2214, 5850/5980 University Avenue, Halifax, Nova Scotia B3K 6R8, Canada; Department of Community Health & Epidemiology, Dalhousie University, G-2214, 5850/5980 University Avenue, Halifax, Nova Scotia B3K 6R8, Canada. Electronic address: https://twitter.com/souvik_neo.
Publications dans "Persistance du canal artériel" :
Department of Pediatrics, The Ohio State University Wexner Medical Center, Columbus, OH, USA; The Heart Center, Nationwide Children's Hospital, Columbus, OH, USA.
Publications dans "Persistance du canal artériel" :
Department of Pediatrics, The Ohio State University Wexner Medical Center, Columbus, OH, USA; Center for Perinatal Research, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, USA; Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH, USA.
Publications dans "Persistance du canal artériel" :
Department of Pediatrics, The Ohio State University Wexner Medical Center, Columbus, OH, USA; The Heart Center, Nationwide Children's Hospital, Columbus, OH, USA; Center for Perinatal Research, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, USA. Electronic address: Carl.Backes@nationwidechildrens.org.
Publications dans "Persistance du canal artériel" :
Department of Pediatrics, Division of Pediatric Cardiology, University of Tennessee Health Science Center, Le Bonheur Children's Hospital, 51 N Dunlap street, Memphis, TN 38105, USA.
Publications dans "Persistance du canal artériel" :
From the Department of Pediatrics, Division of Neonatology (T.H., W.P.B.), and the Department for Health Evidence (R.D.), Radboud University Medical Center, Radboud Institute for Health Sciences, Amalia Children's Hospital, Nijmegen, the Department of Neonatology, Amsterdam Reproduction and Development, Emma Children's Hospital, Amsterdam University Medical Centers (W.O., W.B.V., A.H.K., T.B.), and Neonatology Network Netherlands (D.H.G.M.N.), Amsterdam, University Medical Center Groningen, Beatrix Children's Hospital, and the Department of Pediatrics, Division of Neonatology, University of Groningen (E.M.W.K., P.H.D.), Groningen, the Division of Woman and Baby, Department of Neonatology, University Medical Center Utrecht, Utrecht University, Wilhelmina Children's Hospital, Utrecht (D.C.V., W.B.V.), the Department of Neonatology, Maxima Medical Center Veldhoven, Veldhoven (K.P.D.), Maastricht University Medical Center, the Department of Pediatrics, Division of Neonatology, School for Oncology and Reproduction, University of Maastricht, Maastricht (E.V.), the Department of Pediatrics, Division of Neonatology, Erasmus Medical Center Rotterdam, Sophia Children's Hospital, Rotterdam (A.A.K.), the Department of Pediatrics, Division of Neonatology, Leiden University Medical Center, Willem Alexander Children's Hospital, Leiden (R.V.), and the Department of Pediatrics, Division of Neonatology, Isala Women's and Children's Hospital Zwolle, Zwolle (S.M.M.-T.) - all in the Netherlands; the Department of Neonatology, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel (B.D.B.), the Department of Pediatrics, Division of Neonatology, Hôpital Universitaire des Enfants Reine Fabiola (D.A.), the Department of Pediatrics, Division of Neonatology, Cliniques Universitaires St. Luc (C.H.), the Department of Neonatology, Cliniques Universitaires de Bruxelles, Hôpital Erasme (F.D., B.V.O.), and Kind en Gezin-Opgroeien, Flemish Government, Sint-Gillis (B.V.O.), Brussels, the Department of Pediatrics, Division of Neonatology, Ghent University Hospital, Ghent (A.Z.), and the Department of Neonatology, Antwerp University Hospital, Edegem (A.L.M., M.M.) - all in Belgium; and the Departments of Pediatrics and Adolescent Medicine and Clinical Medicine, Aarhus University Hospital and Aarhus University, Aarhus, Denmark (T.B.H., K.J.K.).
Publications dans "Persistance du canal artériel" :
Since PDA stenting was first attempted in the early 1990s, significant technical advancements have improved outcomes and some centers have even transitioned to exclusive PDA stenting for all infants w...
Transcatheter ductal closure has proven to be safe and effective to occlude the patent ductus arteriosus (PDA) in premature infants. We have developed a robust multidisciplinary PDA program. After gai...
The objective is to determine the efficacy and safety of paracetamol in preterm babies with hemodynamically significant patent ductus arteriosus (hsPDA)....
In preterm babies, patent ductus arteriosus, when hemodynamically significant, causes considerable morbidity and mortality and also affects 20% of very low birth weight infants. Medical therapy is the...
A total of 14 preterm babies diagnosed to have hsPDA on clinical and echocardiographic evaluation in neonatal ICU on days 3-14 of life during 13 months were included. Birth weight was between 1000 g a...
In 12 (86%) out of 14 cases, PDA was closed, whereas in 2 (14%) hemodynamic closure with insignificant residual flow was achieved. Paracetamol was effective in 100% of cases. No adverse event was obse...
Paracetamol is a very safe and efficacious drug for treating hemodynamically significant patent ductus arteriosus in premature babies....
Although rare, paradoxical embolism sometimes occurs with patent ductus arteriosus (PDA). This study presents a case of PDA-associated paradoxical embolism with acute ischemic stroke (AIS) and pulmona...
A 65-year-old woman developed acute-onset aphasia and right hemiparesis on the third day following thoracoscopic resection for a right lung tumor. Brain magnetic resonance imaging revealed multiple in...
For an uncommon but potentially fatal case with PDA-induced paradoxical embolism causing AIS and PE, early recognition and treatment are vital. Further studies are warranted to determine the optimal m...
Bronchopulmonary dysplasia (BPD) is often associated with pulmonary vascular disease and secondary pulmonary hypertension (PH). The pathogenesis of BPD-associated PH (BPD-PH) is complex and involves p...
To explore the association of PDA with BPD-PH using a bayesian model-averaged (BMA) meta-analysis of studies....
PubMed and Embase were searched up to April 2023. Key search terms included BPD and PH....
Studies examining infants with gestational age 32 weeks or less and reporting data on PDA and risk of BPD-PH....
This study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses and the Meta-Analysis of Observational Studies in Epidemiology reporting guidelines. Two independent reviewer...
The primary outcome was BPD-PH. BMA was used to calculate Bayes factors (BFs). The BF10 is the ratio of the probability of the data under the alternative hypothesis (H1, association of PDA with BPD-HP...
A total of 32 studies (8513 infants) were included. BMA showed that the evidence in favor of H1 was weak for any PDA (BF10 = 2.90; 10 studies), moderate for hemodynamically significant PDA (BF10 = 3.7...
In this bayesian meta-analysis, the data suggest that prolonged exposure to PDA might be associated with increased risk of pulmonary vascular disease in extremely preterm infants. This highlights the ...
Percutaneous closure of patent ductus arteriosus using a duct occluder has become standard of care in its management especially in children more than 6 months of age, weighing more than 6 kg but devic...
The ligamentum arteriosum (LA) is the vestigial fibrous remnant of the ductus arteriosus (DA), a fetal vessel arising from the left dorsal segment of the sixth aortic arch that connects the left pulmo...
Conventionally, a chest tube drainage is placed following patent ductus arteriosus (PDA) ligation to monitor possible bleeding and drain air or effusion postoperatively. However, the necessity of ches...
We retrospectively reviewed the medical records of 56 preterm neonates who underwent surgical ligation of PDA via thoracotomy in the neonatal intensive care unit between January 2014 and March 2022....
The median gestational age was 26.9 (interquartile range [IQR]: 25.9-28.8) weeks and the median body weight at birth was 895 (IQR: 795-1190) g. The median age on the day of surgery was 17.0 (IQR: 10.0...
Omitting chest tube drainage is feasible and safe for the postoperative management of preterm neonates undergoing PDA ligation via thoracotomy....
Milrinone is administered after patent ductus arteriosus (PDA) ligation to prevent and treat postoperative hemodynamic instability (i.e., postligation cardiac syndrome). We aimed to explore the effect...
Using the Japanese Diagnosis Procedure Combination database, we identified patients who received milrinone after PDA ligation (n = 428) in neonatal intensive care units between July 2010 and March 202...
In-hospital morbidity, bronchopulmonary dysplasia, intraventricular hemorrhage, and necrotizing enterocolitis occurred in 58%, 48%, 9.5%, and 7.1% of patients, respectively; the in-hospital mortality ...
Milrinone use after PDA ligation was not associated with improved in-hospital outcomes, such as mortality and morbidity....
Ductal patency of preterm infants is potentially associated with long term morbidities related to either pulmonary overflow or systemic steal. When an interventional closure is needed, it can be achie...